HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

prednicarbate (Batmen)

Subscribe to New Research on prednicarbate

Also Known As:

Batmen; Dermatop; Aventis brand of prednicarbate; Dermik brand of prednicarbate; HOE 777; HOE-777; Menarini brand of prednicarbate; Novag brand of prednicarbate; Ortho brand of prednicarbate; Peitel; prednisolone-17-ethylcarbonate-21-propionate; Pregna-1,4-diene-3,20-dione, 17-((ethoxycarbonyl)oxy)-11-hydroxy-21-(1-oxopropoxy)-, (11beta)-

Networked: 42 relevant articles (5 outcomes, 7 trials/studies)

Relationship Network

Drug Context: Research Results

Polycyclic Compounds: 56
- Steroids: 18537
  - Pregnanes: 3
    - Pregnadienes
      - Pregnadienetriols
        Prednisolone: 8159
        prednicarbate: 42

Experts

1.	Borchert, Hans-Hubert: 2 articles (07/2012 - 01/2010)
2.	Baspinar, Yücel: 2 articles (07/2012 - 01/2010)
3.	Wollenberg, Andreas: 2 articles (01/2012 - 01/2010)
4.	Chow, Melody: 2 articles (09/2004 - 07/2004)
5.	Gupta, Aditya K: 2 articles (09/2004 - 07/2004)
6.	Korting, H C: 2 articles (07/2004 - 05/2003)
7.	Schäfer-Korting, M: 2 articles (07/2004 - 05/2003)
8.	Ruiz-González, Inmaculada: 1 article (07/2015)
9.	Pérez-Bustillo, Alicia: 1 article (07/2015)
10.	Rodríguez-Prieto, Manuel-Ángel: 1 article (07/2015)

Related Diseases

1.	Atopic Dermatitis (Atopic Eczema) 07/01/2001 - "In conclusion, this study found prednicarbate emollient cream 0.1% to be safe and effective for the treatment of atopic dermatitis in pediatric patients for up to 3 weeks." 06/01/1997 - "Evaluation of skin layer-specific prednicarbate (PC) biotransformation, possibly explaining the improved benefit/risk ratio of this topical corticosteroid in atopic dermatitis (1,2). " 07/01/2001 - "A multicenter, 3-week, open-label study evaluated prednicarbate emollient cream 0.1%, a nonhalogenated midpotency corticosteroid, in 55 patients aged 4 months to 12 years who were diagnosed with atopic dermatitis. " 01/04/2010 - "A physically and chemically stable positively charged prednicarbate nanoemulsion was developed as a carrier system for the treatment of atopic dermatitis. " 12/01/2004 - "Thus, prednicarbate may be a consideration in the treatment of atopic dermatitis in children, and other inflammatory disorders in children and adults."
2.	Pruritus (Itching) 06/01/2008 - "If a flare occurred, defined as an exacerbation (unacceptable severity of itching/scratching or onset of oozing) not controlled by study medication, patients were treated with prednicarbate 0.25% cream instead. " 04/01/2006 - "Silver textiles reduced the severity of the pruritus (p = 0.031); silver-free textiles (n.s.) and prednicarbate (n.s.) were less effective. " 01/01/1998 - "Prednicarbate is indicated for relief of inflammation and pruritus associated with corticosteroid-responsive dermatological disorders such as dermatitis (eczema) [including atopic dermatitis] and psoriasis and can be used in children and elderly patients. "
3.	Atrophy 09/01/2004 - "Prednicarbate has been found to have a favorable benefit-risk ratio, with low skin atrophy potential, and a high anti-inflammatory action. " 01/01/1992 - "0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream." 03/01/2002 - "Prednicarbate is a topical glucocorticoid with an improved benefit/risk ratio, as it causes less skin atrophy than the equipotent betamethasone 17-valerate." 03/01/2002 - "Visible signs of atrophy or telangiectasia were detected in two subjects each upon betamethasone 17-valerate and mometasone furoate, but not upon prednicarbate or its vehicle. "
4.	Exanthema (Rash) 01/01/2012 - "Strikingly, patients' rash severity improved significantly over three weeks of treatment with topical mometason furoate cream, topical prednicarbate cream plus nadifloxacin cream, as well as topical prednicarbate cream plus nadifloxacin cream plus systemic isotretinoin. "
5.	Skin Diseases 01/01/1998 - "Therefore, prednicarbate is a useful option for the treatment of corticosteroid-responsive dermatoses and appears to have low atrophogenic potential when used without occlusion." 01/01/1986 - "[Photographic follow-up of the topical use of prednicarbate preparations in inflammatory dermatoses]." 11/15/1989 - "[Eczema diseases and erythemato-squamous dermatoses of aging skin--studies of the effectiveness and tolerance of Prednicarbate in various vehicles]." 12/01/2004 - "Prednicarbate is a nonhalogenated corticosteroid that is used in the treatment of inflammatory skin diseases, for example atopic dermatitis. " 11/15/1989 - "Prednicarbate, therefore, is especially suitable in the treatment of eczemas and chronic erythematosquamous dermatoses of aged skin."

Related Drugs and Biologics

1.	Betamethasone 17-Valerate (Betamethasone 17 Valerate)
2.	nadifloxacin
3.	Isotretinoin (Accutane)
4.	Silver
5.	Hydrocortisone (Cortisol)
6.	Adrenal Cortex Hormones (Corticosteroids)
7.	Cetirizine (Zyrtec)
8.	Betamethasone (Celestone)
9.	pimecrolimus (Elidel)
10.	prednicarbate (Batmen)

Related Therapies and Procedures

1.	Oral Administration
2.	Drug Therapy (Chemotherapy)